Peritoneal VEGF burden as a predictor of cytoreductive surgery outcome in women with epithelial ovarian cancer

International Journal of Gynecology and Obstetrics

Volumn 109, Issue 2, 2010, Pages 113-117

  Diniz Bizzo, Solange Maria ^a   Meira, Débora Dummer ^a,b   Lima, José Marinaldo ^a   Mororó, Jânio da Silva ^b   Casali da Rocha, José Cláudio ^a   Ornellas, Maria Helena Faria ^a,b  

^a National Cancer Institute   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiogenesis; Ovarian cancer; Prognosis; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; PATIENT SELECTION; PERITONEAL FLUID LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS;

EID: 77950519933     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.11.021     Document Type: Article

References (25)

1. Ozols R.F., Rubin S.C., Thomas G.M., and Robboy S.J. Epithelial ovarian cancer. In: Hoskins W.J., Perez C.A., Yong R.C., Barakat R.R., Markman M., and Randall M.E. (Eds). Principles and Practice of Gynecologic Oncology (2005), Lippincott Willians & Wilkins, Philadelphia 825-987
2. Lee J.W., Shahzad M.M., Lin Y.G., Armaiz-Pena G., Mangala L.S., Han H.D., et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 15 8 (2009) 2695-2702
3. Arits A.H., Stoot J.E., Botterweck A.A., Roumen F.J., and Voogd A.C. Preoperative serum CA-125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer. Int J Gynecol Cancer 18 4 (2008) 621-628
4. Gemer O., Segal S., and Kopmar A. Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer. Act Obst Gynecol Scand 80 6 (2005) 583-585
5. Mesiano S., Ferrara N., and Jaffe R.B. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. Am J Pathol 153 4 (1998) 1249-1256
6. Griffiths C.T., and Fuller A.F. Intensive surgical and chemotherapy management of advanced ovarian cancer. Surg Clin North Am 58 1 (1978) 131-142
7. Hoskins W.J., McGuire W.P., MfF B., Homesley H.D., Creasman W.T., and Bearman M. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170 4 (1994) 974-979
8. Rasila K.K., Burger R.A., Smith H., Lee F.C., and Verschraegen C. Angiogenesis in gynecological oncology: mechanism of tumor progression and therapeutic targets. Int J Gynecol Cancer 15 5 (2005) 710-726
9. Bamberger E.S., and Perret C.W. Angiogenesis in epithelial ovarian cancer. Mol Pathol 559 6 (2002) 348-359
10. Hefler L.A., Zeillinger R., Grimm C., Sood A.K., Cheng W.F., Gadducci A., et al. Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer. Gynecol Oncol 103 2 (2006) 512-517
11. Rudlowski C., Pickart A.K., Fuhljahn C., Friepoertner T., Schlehe B., Biesterfeld S., et al. Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer 16 1 (2006) 183-189
12. O'Toole S.A., Sheppard B.L., Laios A., O'Leary J.J., McGuinness E.P.J., D'Arcy T., et al. Potential predictors of chemotherapy response in ovarian cancer: how do we define chemosensitivity?. Gynecol Oncol 104 2 (2007) 345-351
13. Obermair A., Bancher-Todesca D., Bilgi S., Kaider A., and Kohlberger P. Correlation of vascular endothelial growth factor expression and microvessel density in cervicalintraepithelial neoplasia. J Natl Cancer Inst 89 16 (1997) 1212-1217
14. Yamamoto S., Konishi I., Mandai M., Kuroda H., Komatsu T., Nanbu K., et al. Expression of vascular endothelial growth factor (VEGF) in epithelial neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 76 9 (1997) 1221-1227
15. Tempfer C., Obermair A., Hefler L., Hausler G., Gitsch G., and Kainz C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol 92 3 (1998) 360-363
16. Chen C.A., Cheng W.F., Lee C.N., Chen T.M., Kung C.C.S., Hsieh F.J., et al. Serum vascular endothelial growth factor in epithelial ovarian neoplasm: correlation with patient survival. Gynecol Oncol 74 2 (1999) 235-240
17. Cooper B.C., Ritchie J.M., Broghammer C.L., Coffin J., Sorosky J.I., Buller R.E., et al. Preoperative serum vascular VEGF levels: significance in ovarian cancer. Clin Cancer Res 8 10 (2002) 3193-3197
18. Secord A.A., Sayer R., Snyder S.A., Broadwater G., Rodriguez G.C., Berchuck A., et al. The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second look laparotomy in ovarian cancer. Gynecol Oncol 94 1 (2004) 74-79
19. Chi D.S., Zivanovic O., Palayekar M.J., Eisenhauer E.L., Abu-Rustum N.R., Sonoda Y., et al. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol 112 1 (2009) 6-10
20. Kraft A., Weindel K., Ochs A., Marth C., Zmija J., Schumacher, et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 85 1 (1999) 178-187
21. Nascimento I., Schaer R., Lemaire D., Freire S., Paule B., Carvalho S., et al. Vascular endothelial growth factor (VEGF) levels as a tool to discriminate between malignant from nonmalignant ascites. APMIS 112 9 (2004) 585-587
22. Dong W.G., Sun X.M., Yu B.P., Luo H.S., and Yu J.P. Role of VEGF and CD44v6 in differentiating benign from malignant ascites. World J Gastroenterol 9 11 (2003) 2596-2600
23. Yabushita H., Shimazu M., Noguchi M., Kishida T., Narumiya H., Sawaguchi K., et al. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Oncol Rep 10 1 (2003) 89-95
24. Zebrowski B.K., Liu W., Ramirez K., Akagi Y., Mills G.B., and Ellis L.M. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 6 4 (1999) 373-378
25. Yoneda J., Kuniyasu H., Crispens M., Price J., Bucana C., and Fidler I. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 90 6 (1998) 447-454